Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer

Huan Wu; Rongrong Li; Zhiwei Zhang; Huiyang Jiang; Hanlin Ma; Cunzhong Yuan; Chenggong Sun; Yingwei Li; Beihua Kong

doi:10.1186/s13048-020-00628-5

Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer

J Ovarian Res. 2020 Mar 13;13(1):28. doi: 10.1186/s13048-020-00628-5.

Authors

Huan Wu^{1

2}, Rongrong Li^{1

2}, Zhiwei Zhang^{1

2}, Huiyang Jiang^{1

2}, Hanlin Ma^{1

2}, Cunzhong Yuan^{1

2}, Chenggong Sun^{1

2}, Yingwei Li^{1

2}, Beihua Kong^{3

4}

Affiliations

¹ Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, 107 Wenhua Xi Road, Ji'nan, Shandong, 250012, People's Republic of China.
² Shandong Key Laboratory of Gynecologic Oncology, Qilu Hospital of Shandong University, Ji'nan, Shandong, People's Republic of China.
³ Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University, 107 Wenhua Xi Road, Ji'nan, Shandong, 250012, People's Republic of China. kongbeihua@sdu.edu.cn.
⁴ Shandong Key Laboratory of Gynecologic Oncology, Qilu Hospital of Shandong University, Ji'nan, Shandong, People's Republic of China. kongbeihua@sdu.edu.cn.

Abstract

The original article [1] contains errors in Fig. 3C, Results and Discussion.

Publication types

Published Erratum